Trial Profile

Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-08: a Phase 1 Study of SC-DARIC33 in Pediatric and Young Adults with Relapsed or Refractory CD33+ AML

Status: Suspended

Phase of Trial: Phase I

Latest Information Update: 07 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DARIC-33 (Primary) ; Sirolimus
Indications Acute myeloid leukaemia
Focus Adverse reactions; First in man
Acronyms PLAT-08

Most Recent Events

29 Feb 2024 Planned End Date changed from 31 Jan 2039 to 31 Jan 2041.
29 Feb 2024 Planned primary completion date changed from 29 Feb 2024 to 28 Feb 2026.
12 Sep 2023 According to a 2seventy bio media release, company will provide the next update on the PLAT-08 study upon completion of the Phase I dose escalation.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com